EHA/ESMO Clinical Practice Guidelines for the Management of Malignant Lymphoma: Recommendations for the Second Phase of the COVID-19 Pandemic
Hemasphere
.
2021 Jan 27;5(2):e529.
doi: 10.1097/HS9.0000000000000529.
eCollection 2021 Feb.
Authors
Martin Dreyling
1
,
Igor Aurer
2
,
Massimo Federico
3
,
Mats Jerkeman
4
,
Marie Jose Kersten
5
,
Kim Linton
6
,
Ulrich Mey
7
,
Herve Tilly
8
,
Christian Buske
9
Affiliations
1
Department of Medicine III, LMU Hospital, Munich, Germany.
2
Department of Medicine, University Hospital Centre Zagreb and Medical School, Zagreb, Croatia.
3
Medical Oncology, CHIMOMO Department, University of Modena and Reggio Emilia, Modena, Italy.
4
Department of Oncology, Skåne University Hospital, Lund, Sweden.
5
Department of Hematology, Amsterdam UMC, The Netherlands.
6
Manchester Cancer Research Centre, University of Manchester, United Kingdom.
7
Oncology and Haematology, Kantonsspital Graubuenden, Chur, Switzerland.
8
Department of Hematology, Centre Henri Becquerel, University of Rouen, France.
9
CCC Ulm, University Hospital Ulm, Germany.
PMID:
33880434
PMCID:
PMC8051991
DOI:
10.1097/HS9.0000000000000529
No abstract available
Publication types
Review